Congratulations to our client, LAMF Ventures Corp. I (NASDAQ: LGVC), on the completion of its business combination with Nuvo Group Ltd., a leading innovator in women’s health and connected pregnancy care! The two companies are now wholly-owned subsidiaries of a new company, valued at approximately $300 million at closing, whose shares will begin trading on Nasdaq today. In addition to advising on the business combination agreement, we assisted LAMF with an investment in preferred shares of Nuvo, obtaining rulings from the Israeli Tax Authority and a prospectus exemption from the Israeli Securities Authority, the Israeli merger process, and the prospectus filed with the U.S. Securities and Exchange Commission.

This deal won the LMG Life Sciences 2024 Impact Deal of the Year Award!

The team was led by Ory Nacht, Michal Herzfeld and Ben Wahlhaus, of our corporate and securities department, and included Dr. Ehab Farah and Eldad Hamam (tax), Shachar Porat and Niran Ferman (equity incentives), Ofer Granot and Dor Furer (government benefits), Adar Bengom (Ortal) (intellectual property), Nir Gal (employment), Olga Pery (data privacy), and Yaakov Rosenblum (corporate).